APA (7th ed.) Citation

Capaldi, D., Teasdale, A., Henry, S., Akhtar, N., den Besten, C., Gao-Sheridan, S., . . . Foy, J. (2017). Impurities in Oligonucleotide Drug Substances and Drug Products. Nucleic acid therapeutics, 27(6), 39-322. https://doi.org/10.1089/nat.2017.0691

Chicago Style (17th ed.) Citation

Capaldi, Daniel, et al. "Impurities in Oligonucleotide Drug Substances and Drug Products." Nucleic Acid Therapeutics 27, no. 6 (2017): 39-322. https://doi.org/10.1089/nat.2017.0691.

MLA (9th ed.) Citation

Capaldi, Daniel, et al. "Impurities in Oligonucleotide Drug Substances and Drug Products." Nucleic Acid Therapeutics, vol. 27, no. 6, 2017, pp. 39-322, https://doi.org/10.1089/nat.2017.0691.